Industry reports
Editor highlights

Drug and Medication Industry in Australia: Market Research Reports, Statistics and Analysis

You might be interested in: drug, medicine, vaccine, more »

» View Public Reports

About 200 reports

Drug and Medication Sector in The United States and Australia

  • Industry report
  • March 2014
  • 33 pages
  • by Corporation

... To serious infections and malignancy costs of current anti-tnf drug treatments are approximately $18-30k / year infliximab (remicade ) has been shown to have anti-map activity * hanauer at al ...

The Australian Drug and Medication Industry

  • Industry report
  • March 2013
  • 32 pages

... For multiple suppliers Low marginal cost of production The (relevant) policy issue is what should the subsidised price be 6 Grattan analyses Identified the 50 drug-dose combinations that are highest ...

Drug and Medication Sector in India and Australia

  • Industry report
  • September 2012
  • 25 pages
  • by Intergovernmental Agency

... India S largest market leader in antimalarial over 3 decades Antimalarial constitutes around 24% of ipca S annual sale Us$ 115 mln Ipca S artemether + lumefantrine tabs tender sale ...

Drug and Medication Sector in New Zealand, Australia and The United Kingdom

  • Industry report
  • July 2012
  • 8 pages

... Pharmacist-only medicines that legally require pharmacist involvement in supply. The exemption to pre- scription supply used for oseltamivir is similar, requiring pharma- cist involvement, but only allows ...

The Australian Drug and Medication Business Brief

  • Industry report
  • June 2012
  • 6 pages

Drug and Medication in Australia : Innovation and Technology Trends

  • Industry report
  • May 2012
  • 51 pages

... Humour smile study elder clowns & laughterbosses reduce agitation clinically significant 20% Reduction in agitation symptoms in smile The same effect size as is achieved by antipsychotic medications ...

Drug and Medication Market in Australia

  • Industry report
  • April 2012
  • 30 pages

... Random testing for drug driving 11% Workplace drug testing Kronic seen as less likely to be detected than cannabis by: Workplace drug testing (76%) Sniffer dogs (79%) market characteristics ...

Drug and Medication Market in Australia, South Korea and India

  • Industry report
  • April 2012
  • 9 pages

... And consuming focus. We expect that by year S end we will have commenced our phase 3 trial for oxycodone, as well as establishing the international division of our personal care business, bioelixia . We ...

Drug Business in Australia, The United States and Mexico

  • Industry report
  • February 2012
  • 49 pages

... What do countries do Global drug prohibition developed slowly, many decades Countries now very similar policy drugs defined primarily as a criminal justice problem Harsh rhetoric ...

Ear Care in Australia

  • Industry report
  • July 2013
  • 3 pages

The Ear Care in Australia Capsule provides headlines, market size and competitive analysis alongside a set of charts including company shares, national brand owners and fore...

Search in Drug and Medication Industry

» Purchase Premium Reports (From $ 250 - $ 1 231)

92 reports
Australia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Australia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Australia’s pharmaceutical segment will get increasingly more regulated as the government seeks to make improvements for creating a more transparent environment, benefiting all stakeholders: ...

Australia Pharmaceuticals And Healthcare Report Q1 2014

February 2014 $ 1 300

Mylan Laboratories Limited - Strategic Swot Analysis Re ...

February 2014 $ 300

Henderson Morley Plc - Pharmaceuticals & Healthcare - D ...

February 2014 $ 250

Edmond Pharma Srl - Pharmaceuticals & Healthcare - Deal ...

January 2014 $ 250

Edmond Pharma Srl - Pharmaceuticals & Healthcare - Deal ...

January 2014 $ 250

Avexa Limited (symbol:avx) Swot Analysis, Strategy, Rev ...

January 2014 $ 125

Aspen Pharmacare Holdings Ltd (symbol:apn) Swot Analysi ...

January 2014 $ 125

Idt Australia Limited (symbol:idt) Swot Analysis, Strat ...

January 2014 $ 125

Haemophilus Influenzae Type B Infections - Pipeline Rev ...

November 2013 $ 2 000

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.